Cargando…
Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation
BACKGROUND: Since Canadian drug regulatory approval of mifepristone for medical abortion in 2015 and its market availability in January 2017, the role of pharmacists in abortion provision has changed rapidly. We sought to identify the factors that influenced the initiation and provision of medical a...
Autores principales: | Munro, Sarah, Wahl, Kate, Soon, Judith A., Guilbert, Edith, Wilcox, Elizabeth S., Leduc-Robert, Genevieve, Ansari, Nadra, Devane, Courtney, Norman, Wendy V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330203/ https://www.ncbi.nlm.nih.gov/pubmed/34344393 http://dx.doi.org/10.1186/s13012-021-01144-w |
Ejemplares similares
-
Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists
por: Zusman, Enav Z, et al.
Publicado: (2022) -
Dispensing mifepristone for medical abortion in Canada: Pharmacists’ experiences of the first year
por: Zusman, Enav Z., et al.
Publicado: (2023) -
Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers
por: Devane, Courtney, et al.
Publicado: (2019) -
Could implementation of mifepristone address Canada’s urban–rural abortion access disparity: a mixed-methods implementation study protocol
por: Norman, Wendy V, et al.
Publicado: (2019) -
A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study
por: Dunn, Sheila, et al.
Publicado: (2022)